citrulline has been researched along with Diabetic Angiopathies in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allerton, TD; Dugas, TR; Irving, BA; Proctor, DN; Spielmann, G; Stephens, JM | 1 |
Kövamees, O; Pernow, J; Shemyakin, A | 1 |
Eder, M; Meinitzer, A; Pieber, TR; Sourij, H; Tripolt, NJ; Wascher, TC | 1 |
Chang, K; Corbett, JA; Currie, MG; Hasan, KS; McDaniel, ML; Misko, TP; Moore, WM; Petrash, JM; Smith, SR; Tilton, RG | 1 |
1 review(s) available for citrulline and Diabetic Angiopathies
Article | Year |
---|---|
l-Citrulline Supplementation: Impact on Cardiometabolic Health.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Antioxidants; Citrulline; Diabetic Angiopathies; Dietary Supplements; Endothelium, Vascular; Evidence-Based Medicine; Humans; Hypertension; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Models, Biological; Sarcopenia; Vascular Stiffness; Vasodilator Agents | 2018 |
1 trial(s) available for citrulline and Diabetic Angiopathies
Article | Year |
---|---|
Multifactorial risk factor intervention in patients with Type 2 diabetes improves arginine bioavailability ratios.
Topics: Aged; Anticholesteremic Agents; Arginine; Biological Availability; Blood Pressure; Cholesterol, LDL; Citrulline; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Ornithine; Prospective Studies; Risk Factors; Time Factors | 2012 |
2 other study(ies) available for citrulline and Diabetic Angiopathies
Article | Year |
---|---|
Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunction.
Topics: Aged; Arginase; Arginine; Biomarkers; Case-Control Studies; Citrulline; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Forearm; Humans; Male; Middle Aged; Nitric Oxide Synthase; Ornithine; Up-Regulation; Vasodilation | 2016 |
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Topics: Aldehyde Reductase; Amino Acid Oxidoreductases; Animals; Arginine; Benzothiazoles; Blood Pressure; Body Weight; Capillary Permeability; Citrulline; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Glycation End Products, Advanced; Guanidines; Imidazoles; Imidazolidines; Inositol; Iodine Radioisotopes; Male; Methylguanidine; Naphthalenes; Nitric Oxide Synthase; omega-N-Methylarginine; Phthalazines; Rats; Rats, Sprague-Dawley; Retina; Sciatic Nerve; Serum Albumin, Bovine; Sorbitol; Thiazoles; Uvea | 1993 |